Shilpa Medicare Ltd.

₹1,064.1

16.9 (1.6%)

SHILPAMED Share Price

Pharmaceuticals & Biotechnology

As on October 1, 2026

SectorHealthcare

IndustryPharmaceuticals & Biotechnology

Basic IndustryPharmaceuticals

Market Cap₹ 20,803.1 Cr

P/E Ratio85.54

Dividend Yield0.06 %

Trendline Performance

We are partnered with TradingView, a global leader in charting and market analysis. Access real-time stock data, explore the powerful Stock Screener , and uncover insights with multiple tools designed for traders.

Unlock Stock of the Month

T&C*

Technicals

Indicators	Value	Signal
5-DMA	1,041.15	Bullish
10-DMA	1,037.58	Bullish
20-DMA	992.77	Bullish
50-DMA	857.48	Bullish
100-DMA	704.96	Bullish
200-DMA	523.25	Bullish

Historical Performance

1 Year

173.3%

3 Years

493.5%

5 Years

286.2%

10 Years

294.1%

Shareholding Pattern

Values Analysis

Loading chart...

Profit & Loss

Below figures are in Rs. Crores

Particulars	Mar-2026	Mar-2025	Mar-2024	Mar-2023	Mar-2022
Net Sales	15,389	12,864	11,516	10,501	11,455
Total Expenditure	11,580	9,802	9,161	9,618	9,483
Other Income	636	364	172	314	209
Operating Profit	4,445	3,427	2,527	1,197	2,181
Interest	588	755	918	587	412
Depreciation	1,197	1,130	1,079	955	798
Profit Before Tax	2,953	1,223	543	-383	1,023
Consolidated Net Profit	2,433	783	319	-325	607
Adjusted EPS	12	4	2	-2	3

Compounded Sales Growth

10 Years:16.5

5 Years:11.3

3 Years:7.9

TTM:3.6

Compounded Profit Growth

10 Years:17.6

5 Years:10.5

3 Years:21

TTM:25.5

Stock Price CAGR

10 Years:13.5

5 Years:31

3 Years:80.5

TTM:176.6

Return on Equity

10 Years:6.7

5 Years:3.5

3 Years:1.8

last year:12.4

Quarterly Results

Below figures are in Rs. Crores

Particulars	Sep-2024	Dec-2024	Mar-2025	Jul-2025	Sep-2025
Sales	1,70,754	1,35,936	1,28,552	1,22,189	1,05,161
Expenses	63,042	56,557	52,457	45,459	34,856
Operating Profit	1,07,712	79,379	76,096	76,730	70,304
OPM %	63%	58%	59%	63%	67%
Other Income	33,912	31,759	27,333	24,879	18,947
Interest	77,780	58,584	59,248	62,137	53,713
Depreciation	2,345	1,681	1,385	1,277	1,221
Profit Before Tax	61,498	50,873	42,796	38,195	34,318
Tax %	25%	25%	26%	29%	35%
Net Profit	46,149	38,151	31,857	27,296	22,446
EPS in Rs	83	69	58	50	42

Balance Sheet

Below figures are in Rs. Crores

Particulars	Mar-2026	Mar-2025	Mar-2024	Mar-2023	Mar-2022
Share Capital	196	98	87	87	87
Total Reserves	25,716	23,529	18,000	17,746	18,135
Long-Term Borrowings	---	---	---	---	---
Total Non-Current Liabilities	2,495	2,598	5,894	3,451	4,528
Other Current Liabilities	2,529	2,132	1,380	2,766	2,401
Short Term Borrowings	4,116	3,068	3,607	3,442	2,029
Total Liabilities	36,887	32,977	30,830	29,039	28,755
Capital Work in Progress	4,312	4,625	4,030	3,580	1,900
Long Term Loans & Advances	427	377	533	565	939
Currents Investments	---	---	---	---	---
Short Term Loans and Advances	1,596	1,496	912	883	1,022
Total Current Assets	11,098	9,845	8,762	7,696	8,872
Total Assets	36,887	32,977	30,830	29,039	28,755
Adjusted Book Value	132	121	104	205	210

Positive

(80 to 100)

Neutral

(60 to 79)

Negative

(0 to 59)

The stock has a high PE of 85.54, indicating expensive valuation or elevated growth expectations.
Over the last three years, the stock delivered a strong 3-year price CAGR of 80.5%, indicating sustained price appreciation.
The stock carries a beta of 0.9, indicating volatility broadly in line with the market.
In the last financial year, the company reported an EBITDA of ₹4445 million, reflecting positive operating performance.
In the previous financial year, the company generated revenue of ₹15389 million, indicating a large and established business.

Investment Calculator

Investment Amount:₹

Investment Amount: ₹ 1000000

Current Value: ₹ 2764255.1

No. of Shares: 2598 (Approx)

Performance:176.4%

1764255.1

NIFTY Performance: -9.9%

1 day Top Gainers